Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Feb 3 2026
Jan 28 2026
Sep 9 2025
Dec 10 2025
Nov 18 2025